BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21300842)

  • 1. Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes.
    Shao CH; Capek HL; Patel KP; Wang M; Tang K; DeSouza C; Nagai R; Mayhan W; Periasamy M; Bidasee KR
    Diabetes; 2011 Mar; 60(3):947-59. PubMed ID: 21300842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.
    Moore CJ; Shao CH; Nagai R; Kutty S; Singh J; Bidasee KR
    Mol Cell Biochem; 2013 Apr; 376(1-2):121-35. PubMed ID: 23354458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart.
    Tian C; Alomar F; Moore CJ; Shao CH; Kutty S; Singh J; Bidasee KR
    Heart Fail Rev; 2014 Jan; 19(1):101-12. PubMed ID: 23430128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus.
    Shao CH; Tian C; Ouyang S; Moore CJ; Alomar F; Nemet I; D'Souza A; Nagai R; Kutty S; Rozanski GJ; Ramanadham S; Singh J; Bidasee KR
    Mol Pharmacol; 2012 Sep; 82(3):383-99. PubMed ID: 22648972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase.
    Bidasee KR; Zhang Y; Shao CH; Wang M; Patel KP; Dincer UD; Besch HR
    Diabetes; 2004 Feb; 53(2):463-73. PubMed ID: 14747299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
    Torre E; Arici M; Lodrini AM; Ferrandi M; Barassi P; Hsu SC; Chang GJ; Boz E; Sala E; Vagni S; Altomare C; Mostacciuolo G; Bussadori C; Ferrari P; Bianchi G; Rocchetti M
    Cardiovasc Res; 2022 Mar; 118(4):1020-1032. PubMed ID: 33792692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.
    Lacombe VA; Viatchenko-Karpinski S; Terentyev D; Sridhar A; Emani S; Bonagura JD; Feldman DS; Györke S; Carnes CA
    Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1787-97. PubMed ID: 17761517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy.
    Suarez J; Scott B; Dillmann WH
    Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1439-45. PubMed ID: 18799637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy.
    Trost SU; Belke DD; Bluhm WF; Meyer M; Swanson E; Dillmann WH
    Diabetes; 2002 Apr; 51(4):1166-71. PubMed ID: 11916940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation.
    Shao CH; Wehrens XH; Wyatt TA; Parbhu S; Rozanski GJ; Patel KP; Bidasee KR
    J Appl Physiol (1985); 2009 Apr; 106(4):1280-92. PubMed ID: 19131475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin Attenuates Cardiac Dysfunction in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Diabetic Cardiomyopathy.
    Lu J; Dai QM; Ma GS; Zhu YH; Chen B; Li B; Yao YY
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):367-379. PubMed ID: 28779372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cardiac injury with iron-increased oxidative and nitrative modifications of the SERCA2a isoform of sarcoplasmic reticulum Ca(2+)-ATPase in diabetic rats.
    Li X; Li W; Gao Z; Li H
    Biochimie; 2016 Aug; 127():144-52. PubMed ID: 27222135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction.
    Hirsch JC; Borton AR; Albayya FP; Russell MW; Ohye RG; Metzger JM
    Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2314-21. PubMed ID: 15148059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart.
    Vasanji Z; Dhalla NS; Netticadan T
    Mol Cell Biochem; 2004 Jun; 261(1-2):245-9. PubMed ID: 15362510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.
    Sulaiman M; Matta MJ; Sunderesan NR; Gupta MP; Periasamy M; Gupta M
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H833-43. PubMed ID: 20008278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonylation of myosin heavy chains in rat heart during diabetes.
    Shao CH; Rozanski GJ; Nagai R; Stockdale FE; Patel KP; Wang M; Singh J; Mayhan WG; Bidasee KR
    Biochem Pharmacol; 2010 Jul; 80(2):205-17. PubMed ID: 20359464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome.
    Balderas-Villalobos J; Molina-Muñoz T; Mailloux-Salinas P; Bravo G; Carvajal K; Gómez-Viquez NL
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1344-53. PubMed ID: 23997093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α down-regulates sarcoplasmic reticulum Ca²⁺ ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-κB to promoter response element.
    Tsai CT; Wu CK; Lee JK; Chang SN; Kuo YM; Wang YC; Lai LP; Chiang FT; Hwang JJ; Lin JL
    Cardiovasc Res; 2015 Mar; 105(3):318-29. PubMed ID: 25712896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart.
    Ver Heyen M; Heymans S; Antoons G; Reed T; Periasamy M; Awede B; Lebacq J; Vangheluwe P; Dewerchin M; Collen D; Sipido K; Carmeliet P; Wuytack F
    Circ Res; 2001 Oct; 89(9):838-46. PubMed ID: 11679415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.